The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-((2-bromophenyl)amino)-3-oxoprop-1-en-1-yl)-2-methoxyphenyl butane-1-sulfonate ID: ALA5203215
PubChem CID: 168292774
Max Phase: Preclinical
Molecular Formula: C20H22BrNO5S
Molecular Weight: 468.37
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCS(=O)(=O)Oc1ccc(/C=C/C(=O)Nc2ccccc2Br)cc1OC
Standard InChI: InChI=1S/C20H22BrNO5S/c1-3-4-13-28(24,25)27-18-11-9-15(14-19(18)26-2)10-12-20(23)22-17-8-6-5-7-16(17)21/h5-12,14H,3-4,13H2,1-2H3,(H,22,23)/b12-10+
Standard InChI Key: KQDSFCMALOUPPC-ZRDIBKRKSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
-0.3571 0.4124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3574 0.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0693 0.4128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0693 -0.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3592 -0.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3571 -0.4160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0717 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7864 0.4124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5010 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2156 0.4124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5010 1.6502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3592 -1.6493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0739 -2.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7840 -0.8249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 -0.4123 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.2132 -0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9279 -0.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6425 -0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3571 -0.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9119 0.3035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0860 0.3035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9303 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6451 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3571 0.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3571 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6469 2.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9303 1.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6451 -0.4126 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
9 11 2 0
5 12 1 0
12 13 1 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
15 20 2 0
15 21 2 0
10 22 1 0
23 22 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
22 27 1 0
23 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.37Molecular Weight (Monoisotopic): 467.0402AlogP: 4.62#Rotatable Bonds: 9Polar Surface Area: 81.70Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.23CX Basic pKa: ┄CX LogP: 4.76CX LogD: 4.76Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.43Np Likeness Score: -0.74
References 1. Yang YS, Wang B, Zhou KM, Liu J, Jiao QC, Qin P.. (2022) Discovery of derivatives from Spartina alterniflora-sourced moiety as xanthine oxidase inhibitors to lower uric acid., 73 [PMID:35902063 ] [10.1016/j.bmcl.2022.128907 ]